Skip to main content

Advertisement

SpringerLink
Log in

‘Innovation’ nation

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

China is finally embracing biopharmaceutical innovation, but it is innovation that looks different from that in the West.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Size of pool of Chinese students in the United States annually from 2000 to 2018.
Fig. 2: Private investment in Chinese and European biotech companies.
Fig. 3: Countries where key discoveries for new therapeutic modalities have been made since biotech’s inception.
Fig. 4: Granted Chinese invention biotech patents by country of first filing, 2009–2018.
Fig. 5: Lagging life sciences.

Author information

Authors and Affiliations

  1. Business Editor, Nature Biotechnology https://www.nature.com/nbt

    Brady Huggett

Authors
  1. Brady Huggett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brady Huggett.

Supplementary material

Supplementary Table 1

Ties to the West

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huggett, B. ‘Innovation’ nation. Nat Biotechnol 37, 1264–1276 (2019). https://doi.org/10.1038/s41587-019-0306-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-019-0306-9

  • Springer Nature America, Inc.

Search

Navigation